A safety and pharmacokinetic study of intravenous natalizumab in patients with MS. Sheremata WA, Vollmer TL, Stone LA, Willmer-Hulme AJ, Koller M Neurology. 1999 Mar 23; 52(5):1072-4. PMID: 10102433. Abstract CommentRecommendBookmarkWatch